Intervention on AMR at the 148th session of the Executive Board

  29 January 2021

We thank WHO for the comprehensive report and its support, together with donors and partners, to GARDP to develop new treatments to address drug resistance.

The growth of drug-resistant infections is a silent pandemic. If left unchecked, humanity will be unable to treat common infections like pneumonia, infections in newborns or secondary bacterial infections in viral pandemics. Like COVID-19, drug-resistant bacteria can infect anyone, of any age, in any country. Unlike COVID-19, we can prepare now. The drug-resistant microbes are known, and meaningful change can be achieved with sufficient political will and resources.

Member States can take the following measures to strengthen national and global responses to drug resistance:

  • Invest in the development of medical countermeasures (diagnostics, treatments, and vaccines) for priority infections as a critical element of preparedness.
  • Ensure that access to diagnostics, treatments, and vaccines for all is a cornerstone of preparedness and response. New mechanisms should be developed that can accelerate and secure equitable and affordable access to existing and new treatments for drug-resistant infections.
  • Expand global cooperation across geographies and sectors, within a One Health framework. No country organisation or sector can tackle AMR alone.
  • Ensure low- and middle-income countries are equal partners in a comprehensive global response. All countries know how and capacities must be harnessed.

Our collective success in fighting this pandemic will  depend on governments seizing this opportunity to develop a more robust, coordinated and equitable approach.

Further reading: GARDP
Author(s): GARDP
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Evotec

JSS University

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!